Dr. Jin Gao 高劲
Chief Physician
Department of Radiation Oncology, Anhui Provincial Cancer Hospital, Hefei
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Radiotherapy for recurrent and newly diagnosed head and neck tumors, digestive tract tumors, and lung cancer. Expertise includes proton therapy for head and neck tumors, chemotherapy, targeted therapy, immunotherapy, and management of treatment side effects.
Dr. Gao holds a PhD in Oncology from Sun Yat-sen University and completed visiting scholar positions at Dana-Farber Cancer Institute (Harvard) and the University of Miami Cancer Center. With over 20 years in clinical radiotherapy, Dr. Gao focuses on basic and clinical research to improve tumor control and quality of life. Dr. Gao contributed to CMA and CSCO guidelines for nasopharyngeal and esophageal cancer radiotherapy.
Professional roles
- Member, Radiation Oncology Branch, Chinese Medical Association
- Chair, Nasopharyngeal Carcinoma Committee, Anhui Anti-Cancer Association
- Standing Committee Member, Youth Council, China Anti-Cancer Association
- Editorial Board Member, Chinese Journal of Cancer Prevention and Treatment
Name order: in Chinese the family name comes first (Gao Jin). Papers usually list the name as Jin Gao or Gao J.
Selected publications
6 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Radiother Oncol, 2022 (senior author): Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (ARD) in head and neck cancer patients (DERMISHEAD trial)". PubMed 35065148
- Cancer Manag Res, 2021 (senior author): Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study. PubMed 33442292
- Oncotarget, 2017 (senior author): MiR-20a-5p promotes radio-resistance by targeting NPAS2 in nasopharyngeal cancer cells. PubMed 29285299
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers; we checked the papers' affiliations and topics against this doctor's department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion